Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
17 November 2016
Header
Header image
News

News

EFPIA Health Collaboration 2016 Summary Report
17 November 2016

Andrzej Rys, Health Systems and Medical products and Innovation Director at the European Commission, opened the EFPIA Health Collaboration Summit 2016, from 9-10 November, by [...] Read more

From our blog

From our blog

CETA: A Transatlantic Perspective – European Life Science Investment in Canada (Guest blog)
17 November 2016 by Robert Quesnel, Sanofi

Earlier this year, the Director General of BusinessEurope, Mr. Markus J. Beyrer, extended an invitation to me to speak before a distinguished audience, comprised of European and Canadian officials, as well as other industry representatives, at the seat of the European Parliament in Brussels. It was with pleasure that I welcomed this opportunity to speak alongside honourable guests, such as European Commissioner for Trade, Ms. Cecilia Malmström, and the Canadian Ambassador to the European Union, Mr. Daniel Costello. The event was hosted by Mr. Artis Pabriks, a Member of the European Parliament for Latvia, whom I would like to thank for facilitating the discussion and for allowing me the chance to give a presentation on what benefits the EU-Canada Comprehensive Economic Trade Agreement (CETA) represents for a European company such as Sanofi.

Read more

From our blog

Health Collaboration Awards 2016: Cancer Treatment at Home
17 November 2016 by EFPIA

The EFPIA Patient Think Tank established the Health Collaboration Awards in 2015, to share best practice in collaborative projects that address healthcare needs. Entrants include collaborations between patient organisations, industry, local authorities, healthcare systems and other key actors in delivering healthcare.

The winners of the 2016 edition of the Awards were announced at the Health Collaboration Summit, which took place on 9-10 November in Brussels.

This week, we focus on the winner of The Service Delivery Award: Cancer Treatment at Home.

Read more

Events calendar

Events Calendar

Optimising the Development of ATMPs to Meet Patient Needs - The fifth annual regulatory conference organised by the European Biopharmaceutical Enterprises (EBE) in collaboration with the European Medicines Agency (EMA)
On 16/12/2016 (London, UK)

Europe is a world-leader in the development of cutting edge Advanced Therapies Medicinal Products (ATMPs) including gene therapies. This conference, organised in collaboration with the EMA, will feature a gathering of international thought-leaders who will highlight initiatives to improve the access to ATMPs for patients, as well as outline the needs for their development and commercialisation within the EU.

For more information on the programme and to register, click here.

Read more

Events Calendar

The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment - European Meeting of the International Society for Medical Publication Professionals (ISMPP)
From 17/01/2017 to 18/01/2017 (London, UK)

The 2017 European Meeting of the International Society for Medical Publication Professionals (ISMPP) will be held 17-18 January, in London, UK, and it will focus on “The Evolving Role of Publication Professionals in a Multi-Stakeholder Environment”. Two full days of educational programming will provide networking opportunities, interactive roundtables, plenary sessions, member research, and exhibitors displaying cutting edge products and services.

Read more

Events Calendar

Patients as Partners Europe
From 06/02/2017 to 07/02/2017 (London, UK)

Patients as Partners Europe is the only conference putting the patient voice on the same level as industry and government in finding solutions to engage and empower patients in the clinical development and trial process. Join clinical trial leaders from Pharma, Patient Advocacy and Goverment. The programme is co-located with DPharm Europe. 

Read more

Events Calendar

EFGCP Annual Conference 2017 on Meeting the Ethical Standards under the Clinical Trials Regulation: the Burning Questions (and Answers) for Researchers, Sponsors and Patients
From 21/02/2017 to 22/02/2017 (Brussels)

The Clinical Trial Regulation is now less than 2 years away and if we are to grasp this opportunity to improve research and regulation for patient benefit, it’s imperative we look together (public, patients researchers and regulators) at both the procedural requirements and ethical changes required.

As one of the most important, longstanding, European fora for debate around clinical research, bringing all interested parties together, the European Forum for Good Clinical Practice has taken an active role in approaching the new CTR (link meeting April 13th). It is proposed that the 2017 A/C will discuss procedural arrangements already underway and address the ethical challenges that the CTR presents, providing opportunity for debate, access to expertise and examples of how these challenges can be met. Workshops with people who can support and help you to solve your problems will be organised.

Read more

Events Calendar

6th FIP Pharmaceutical Sciences World Congress 2017: Future Medicines For One World
From 21/05/2017 to 24/05/2017 (Stockholm, Sweden)

Systems approaches to drug discovery, development and clinical usage

Join leading pharmaceutical scientists from around the world to discuss cutting-edge research and promising developments. 

Stockholm, Sweden. An exciting venue in which the leading pharmaceutical scientists from across the globe will meet to discuss the medicines of the future. What will be the breakthroughs and the pitfalls? How can we meet the biggest challenges?

The International Pharmaceutical Federation (FIP) is pleased to bring you the 6th PSWC, sponsored by many of the world’s leading pharmaceutical science and educational organisations.

To access the programme, click here.

Read more

Documents

From our blog

Healthier future facts and statistics: Cancer
15 November 2016 (Publications)

The third of our infographic series on condition-specific overviews detailing how a focus on the outcomes agenda can impact positively upon patient [...] Read more

What we are reading

What we are reading

Video: The Waiting Room - Safer, more efficient care starts with a simple scan
14 November 2016 (GS1 Healthcare)

Barcodes can transform patient safety and supply chain efficiency in hospitals. 

Watch the video produced by GS1 Healthcare

Read more

What we are reading

ENABLE takes on Oxford antibiotic resistance programme
17 November 2016 (European Lead Factory)

The University of Oxford takes the next step in targeting antimicrobial resistance, with help of the results and hit compounds delivered by the European Lead Factory. The Oxford team, led by Professor Chris Schofield, has got the opportunity to collaborate with the European Gram-Negative Antibacterial Engine (ENABLE) project to further progress this programme towards clinical development.

Read more

What we are reading

Public-private European partnership (ROADMAP) paves the way for sustainable platform for the generation and analysis of real world evidence in Alzheimer’s disease
17 November 2016 (ROADMAP)

The Real world Outcomes across the Alzheimer’s Disease (AD) spectrum for better care: Multi-modal data Access Platform (ROADMAP) initiative aims to establish a sustainable platform for real world evidence (RWE) data generation.

• ROADMAP aims to identify RWE to better inform regulators on matters of efficacy and safety, providers on cost effectiveness, industry on pricing and manufacturing and scientists on mechanisms and pathways, to accelerate decision-making on re-purposing current treatments and developing new treatments.

• ROADMAP brings together world-leading experts from 22 partner organisations to apply cutting-edge technology to a body of data of unprecedented depth and breadth, drawn from 6 EU Member States (Denmark, France, Netherlands, Spain, Sweden, UK), involving 75 national databases and clinical registries, more than 40 cohorts, several studies and 5 dementia-relevant trials, providing a unique opportunity for RWE in general, as well as in the dementia context.

Read more

What we are reading

PROactive draws to a close, delivers on its promises – an interview with project coordinators
17 November 2016 (IMI)

PROactive was launched in 2009 with the aim of developing an innovative tool to measure physical activity in chronic obstructive pulmonary disease (COPD) patients. The project has now drawn to a close, meeting its main goal. In interview with the IMI Programme Office, PROactive’s scientific coordinator, Thierry Troosters of the University of Leuven, and project coordinator, Mario Scuri of CHIESI Pharmaceuticals, explain how the new tool works and how it will benefit patients.

Read more

Sessions Views

Pictures from the EFPIA Health Collaboration Summit 2016 - A Healthier Future for Europe

Pictures from the EFPIA Health Collaboration Summit 2016 - A Healthier Future for Europe
17 November 2016

View album

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail